Original articleClinical endoscopyPercutaneous transhepatic versus EUS-guided gallbladder drainage for malignant cystic duct obstruction
Graphical Abstract
Section snippets
Patients
Between January 2013 and November 2015, 14 patients with acute cholecystitis or symptomatic gallbladder hydrops as a result of malignant cystic duct obstruction underwent EUS-guided transgastric or transduodenal drainage with a covered metal stent. Patient data were collected via retrospective chart review. A prospectively collected EUS database at Seoul National University Bundang Hospital was reviewed retrospectively to identify consecutive patients.
As a control group, 19 patients with acute
Baseline characteristics
The baseline characteristics of the 14 patients who underwent EUS-GBD and 19 patients who underwent PTGBD during the study period are shown in Table 1. In the EUS-GBD group, the underlying malignancy diagnoses were intrahepatic cholangiocarcinoma (n = 2, 14.3%), common bile duct cancer (n = 3, 21.4%), Klatskin tumor (n = 4, 28.6%), and gallbladder cancer (n = 5, 35.7%). The reasons for EUS-GBD were malignant cystic duct obstruction including acute cholecystitis (n = 11, 78.6%) and painful
Discussion
Malignant cystic duct obstruction is an uncommon adverse event in patients with hepatobiliary malignancy. PTGBD is traditionally considered the treatment of choice for the palliative management of this adverse event, because patients are usually not candidates for cholecystectomy. However, removal of the PTGBD catheter is sometimes difficult, which worsens the quality of life of these patients. In this regard, long-term endoscopic internal drainage is a more attractive option than external
References (34)
- et al.
Acute acalculous cholecystitis
Gastroenterol Clin North Am
(2010) - et al.
Can endoscopic ultrasound help to drain the gallbladder?
Gastrointest Interv
(2013) - et al.
Endoscopic gallbladder drainage compared with percutaneous drainage
Gastrointest Endosc
(2015) - et al.
Endoscopic ultrasound-guided transmural and percutaneous transhepatic gallbladder drainage are comparable for acute cholecystitis
Gastroenterology
(2012) - et al.
Endoscopic nasogallbladder tube or stent placement in acute cholecystitis: a preliminary prospective randomized trial in Japan (with videos)
Gastrointest Endosc
(2015) - et al.
Percutaneous biliary interventions through the gallbladder and the cystic duct: what radiologists need to know
Clin Radiol
(2014) - et al.
EUS-guided cholecystenterostomy: a new technique (with videos)
Gastrointest Endosc
(2007) - et al.
Endoscopic transduodenal drainage of the gallbladder: implications for endoluminal treatment of gallbladder disease
Gastrointest Endosc
(2007) - et al.
EUS-guided transmural cholecystostomy as rescue management for acute cholecystitis in elderly or high-risk patients: a prospective feasibility study
Gastrointest Endosc
(2007) - et al.
EUS-guided cholecystoenterostomy with single-step placement of a 7F double-pigtail plastic stent in patients who are unsuitable for cholecystectomy: a pilot study (with video)
Gastrointest Endosc
(2010)
Feasibility and safety of EUS-guided transgastric/transduodenal gallbladder drainage with single-step placement of a modified covered self-expandable metal stent in patients unsuitable for cholecystectomy
Gastrointest Endosc
Clinical evaluation of a novel lumen-apposing metal stent for endosonography-guided pancreatic pseudocyst and gallbladder drainage (with videos)
Gastrointest Endosc
EUS-guided transenteric gallbladder drainage with a new fistula-forming, lumen-apposing metal stent
Gastrointest Endosc
Single-step EUS-guided puncture and delivery of a lumen-apposing stent for gallbladder drainage using a novel cautery-tipped stent delivery system
Gastrointest Endosc
A newly designed fully covered metal stent for lumen apposition in EUS-guided drainage and access: a feasibility study (with videos)
Gastrointest Endosc
Acute acalculous cholecystitis in critically injured patients. Preoperative diagnostic imaging
Ann Surg
Acute acalculous cholecystitis: incidence, risk factors, diagnosis, and outcome
Am Surg
Cited by (54)
Endoscopic Management of Acute Cholecystitis
2022, Gastrointestinal Endoscopy Clinics of North AmericaTrial sequential analysis of EUS-guided gallbladder drainage versus percutaneous cholecystostomy in patients with acute cholecystitis
2022, Gastrointestinal EndoscopyCitation Excerpt :Finally, 9 studies met the inclusion criteria after assessment of the full articles and were considered for data extraction. Of those 9, 3 studies reporting outcomes after drainage with stents other than LAMSs9-11 and 1 study that reported mixed results from transpapillary and transmural EUS-GBD12 were excluded. Additionally, another study from 201613 was subsequently updated and enlarged in 2019,14 and the latter was retained for the analyses.
Comparison of EUS-guided endoscopic transpapillary and percutaneous gallbladder drainage for acute cholecystitis: a systematic review with network meta-analysis
2021, Gastrointestinal EndoscopyCitation Excerpt :Table 1 depicts assessment of bias. Of the retrospective studies, all 8 were considered very low quality, with studies lacking randomization and allocation concealment.3,14-20 For the 2 randomized controlled trials, the level of evidence was considered moderate to low.12,13
EUS-guided gallbladder drainage versus laparoscopic cholecystectomy for acute cholecystitis: a propensity score analysis with 1-year follow-up data
2021, Gastrointestinal EndoscopyCitation Excerpt :This suggests that EUS-GBD may reduce the risk of gallstone-related adverse events, and this may be a potential option in the group of patients who do not want to undergo cholecystectomy. EUS-GBD is gaining popularity as an option of draining the gallbladder in patients at very high risk of cholecystectomy.1-17 In a recently completed randomized controlled trial of EUS-GBD and percutaneous cholecystostomy, EUS-GBD was associated with reduced 1-year adverse events (25.6% vs 77.5%, P < .001), 30-day adverse events (12.8% vs 47.5%, P = .010), reinterventions after 30 days (2.6% vs 30%, P = .001), number of unplanned readmissions (15.4% vs 50%, P = .002), and recurrent cholecystitis (2.6% vs 20%, P = .029).
DISCLOSURE: All authors disclosed no financial relationships relevant to this publication.
If you would like to chat with an author of this article, you may contact Dr Kim at [email protected].